Evidence map›Paper›PMID 33297427›Full record

ArticleMolecules (Basel, Switzerland)2020

Jianmei Zhang, Mi-Yeon Kim, Jae Youl Cho

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Molecules (Basel, Switzerland) · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jianmei ZhangDepartment of Integrative Biotechnology, and Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.ORCID 0000-0003-0817-4809
Mi-Yeon KimSchool of Systems Biomedical Science, Soongsil University, Seoul 06978, Korea.
Jae Youl ChoDepartment of Integrative Biotechnology, and Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.ORCID 0000-0001-8141-9927
Sungkyunkwan University · KRSoongsil University · KR

Funding

National Research Foundation of Korea 2016R1D1A1B01011371National Research Foundation of Korea 2017R1A6A1A03015642
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAnti-Inflammatory AgentsEvodiaHEK293 CellsHumansMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesMethanolMiceNitric OxidePlant ExtractsRAW 264.7 CellsSignal TransductionSolventsTranscription Factor AP-1Anti-Inflammatory AgentsMAP Kinase Kinase Kinase 7MAP Kinase Kinase KinasesMethanolNitric OxidePlant ExtractsSolventsTranscription Factor AP-1anti-inflammatoryAP-1Euodia pasteurianaTAK1

Identifiers

PMID33297427
PMCPMC7730574
OpenAlexW3113102619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.